News Conference News TCT 2022 Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test Shelley Wood September 18, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ESC 2022 New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment Shelley Wood September 01, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News AHA Urges More Home-Based Dialysis in Advanced Kidney Failure Michael O'Riordan August 18, 2022
News Features As US Abortion Protections Are Lost, Cardiologists Brace for Impact Todd Neale June 24, 2022
News Daily News ESC Heart Failure 2022 SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH Shelley Wood May 22, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
Presentation THT 2022 CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Liviu Klein February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022
News Conference News PCR London Valves 2021 MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND Shelley Wood November 26, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF Michael O'Riordan April 15, 2021
News Conference News AHA 2020 One in Five Patients Admitted With COVID-19 Die in the Hospital Michael O'Riordan November 20, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians Caitlin E. Cox April 09, 2020